JP2006518731A5 - - Google Patents

Download PDF

Info

Publication number
JP2006518731A5
JP2006518731A5 JP2006502681A JP2006502681A JP2006518731A5 JP 2006518731 A5 JP2006518731 A5 JP 2006518731A5 JP 2006502681 A JP2006502681 A JP 2006502681A JP 2006502681 A JP2006502681 A JP 2006502681A JP 2006518731 A5 JP2006518731 A5 JP 2006518731A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
heart failure
acceptable salt
benzazepine
severe heart
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006502681A
Other languages
English (en)
Japanese (ja)
Other versions
JP4771937B2 (ja
JP2006518731A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2004/002085 external-priority patent/WO2004073716A1/en
Publication of JP2006518731A publication Critical patent/JP2006518731A/ja
Publication of JP2006518731A5 publication Critical patent/JP2006518731A5/ja
Application granted granted Critical
Publication of JP4771937B2 publication Critical patent/JP4771937B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2006502681A 2003-02-24 2004-02-23 重症心不全の治療方法およびその薬剤 Expired - Lifetime JP4771937B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44887803P 2003-02-24 2003-02-24
US60/448,878 2003-02-24
PCT/JP2004/002085 WO2004073716A1 (en) 2003-02-24 2004-02-23 Method for treating severe heart failure and medicament therefor

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011049403A Division JP2011148806A (ja) 2003-02-24 2011-03-07 重症心不全の治療方法およびその薬剤

Publications (3)

Publication Number Publication Date
JP2006518731A JP2006518731A (ja) 2006-08-17
JP2006518731A5 true JP2006518731A5 (enExample) 2006-11-24
JP4771937B2 JP4771937B2 (ja) 2011-09-14

Family

ID=32908667

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006502681A Expired - Lifetime JP4771937B2 (ja) 2003-02-24 2004-02-23 重症心不全の治療方法およびその薬剤
JP2011049403A Pending JP2011148806A (ja) 2003-02-24 2011-03-07 重症心不全の治療方法およびその薬剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011049403A Pending JP2011148806A (ja) 2003-02-24 2011-03-07 重症心不全の治療方法およびその薬剤

Country Status (23)

Country Link
US (2) US7423032B2 (enExample)
EP (2) EP2000142A1 (enExample)
JP (2) JP4771937B2 (enExample)
KR (1) KR100706727B1 (enExample)
CN (1) CN100577171C (enExample)
AR (1) AR043259A1 (enExample)
AT (1) ATE411803T1 (enExample)
AU (2) AU2004212842B9 (enExample)
BR (1) BRPI0405657A (enExample)
CA (1) CA2493475A1 (enExample)
CY (1) CY1108583T1 (enExample)
DE (1) DE602004017283D1 (enExample)
DK (1) DK1596868T3 (enExample)
ES (1) ES2315640T3 (enExample)
MX (1) MXPA05001623A (enExample)
MY (1) MY143740A (enExample)
NO (1) NO335369B1 (enExample)
PL (2) PL404315A1 (enExample)
PT (1) PT1596868E (enExample)
RU (2) RU2346689C2 (enExample)
SI (1) SI1596868T1 (enExample)
TW (1) TWI322689B (enExample)
WO (1) WO2004073716A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7468390B2 (en) * 2002-01-17 2008-12-23 Novartis Ag Methods of treatment and pharmaceutical composition
TWI322689B (en) * 2003-02-24 2010-04-01 Otsuka Pharma Co Ltd Method for treating severe heart failure and medicament therefor
DE102005003632A1 (de) 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Katheter für die transvaskuläre Implantation von Herzklappenprothesen
US20070213813A1 (en) 2005-12-22 2007-09-13 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
US20100004206A1 (en) 2005-12-27 2010-01-07 Makoto Komatsu Water-soluble benzoazepine compound and its pharmaceutical composition
JP5076327B2 (ja) * 2006-02-01 2012-11-21 味の素株式会社 分岐鎖アミノ酸の心不全適応
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
CN103550233A (zh) * 2007-05-15 2014-02-05 大塚制药株式会社 使用血管加压素拮抗剂与蒽环类化疗试剂以减少心脏中毒和/或提高存活率的方法
TWI405574B (zh) * 2007-06-21 2013-08-21 Otsuka Pharma Co Ltd 藥學固體製劑及其製造方法
BR112012021347A2 (pt) 2008-02-26 2019-09-24 Jenavalve Tecnology Inc stent para posicionamento e ancoragem de uma prótese valvular em um local de implantação no coração de um paciente
US9044318B2 (en) 2008-02-26 2015-06-02 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis
US10856978B2 (en) 2010-05-20 2020-12-08 Jenavalve Technology, Inc. Catheter system
JP2013526388A (ja) 2010-05-25 2013-06-24 イエナバルブ テクノロジー インク 人工心臓弁、及び人工心臓弁とステントを備える経カテーテル搬送体内プロテーゼ
JP5477413B2 (ja) * 2012-04-24 2014-04-23 味の素株式会社 分岐鎖アミノ酸の心不全適応
EP4098226A1 (en) 2013-08-30 2022-12-07 JenaValve Technology, Inc. Endoprosthesis comprising a radially collapsible frame and a prosthetic valve
WO2016150806A1 (en) 2015-03-20 2016-09-29 Jenavalve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath
JP6767388B2 (ja) 2015-05-01 2020-10-14 イェーナヴァルヴ テクノロジー インコーポレイテッド 心臓弁置換におけるペースメーカー割合を低減させるデバイス及び方法
EP4183371A1 (en) 2016-05-13 2023-05-24 JenaValve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
CN110392557A (zh) 2017-01-27 2019-10-29 耶拿阀门科技股份有限公司 心脏瓣膜模拟
CN110174474B (zh) * 2019-05-24 2022-02-18 石家庄四药有限公司 复方电解质注射液(ⅱ)中l-苹果酸异构体的检测方法
CN112121051B (zh) * 2020-09-30 2021-06-18 郑州大学 莫扎伐坦在制备抗消化道肿瘤药物中的应用
US12171658B2 (en) 2022-11-09 2024-12-24 Jenavalve Technology, Inc. Catheter system for sequential deployment of an expandable implant

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01102124A (ja) 1987-10-14 1989-04-19 Kubota Ltd コンクリート構造体支持構造
US5753677A (en) * 1989-10-20 1998-05-19 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclic compounds
US5258510A (en) * 1989-10-20 1993-11-02 Otsuka Pharma Co Ltd Benzoheterocyclic compounds
KR0167349B1 (ko) 1989-10-20 1999-02-18 오스카 아끼히꼬 벤조헤테로 고리 화합물
TW249201B (enExample) 1992-07-02 1995-06-11 Otsuka Pharma Co Ltd
JPH0680641A (ja) 1992-09-01 1994-03-22 Otsuka Pharmaceut Co Ltd 光学活性な5−ヒドロキシベンゾアゼピン誘導体の製造法
TW354762B (en) * 1993-02-23 1999-03-21 Otsuka Pharma Co Ltd Agent for prophylaxis or treatment of cataract
JP2694319B2 (ja) 1993-12-24 1997-12-24 大塚製薬株式会社 抗潰瘍剤
JP3002766B2 (ja) * 1994-12-09 2000-01-24 大塚製薬株式会社 脳浮腫治療剤
JPH10120592A (ja) 1996-10-22 1998-05-12 Otsuka Pharmaceut Co Ltd メニエール病乃至メニエール症候群治療剤
JP4210355B2 (ja) * 1997-07-03 2009-01-14 大塚製薬株式会社 固形製剤組成物
US20030103983A1 (en) * 2002-05-09 2003-06-05 Pressler Milton Lethan Ace inhibitor-vasopressin antagonist combinations
MXPA02006352A (es) 2000-01-26 2002-11-29 Warner Lambert Co Combinaciones del inhibidor ace con el antagonista vasopresina.
US20030008860A1 (en) * 2002-05-09 2003-01-09 Bakker-Arkema Rebecca Guggemos Treatment of congestive heart failure
ATE367815T1 (de) * 2000-10-04 2007-08-15 Astellas Pharma Inc Verwendung von einem vasopressin-antagonisten wie conivaptan zur herstellung eines medikaments für die behandlung der pulmonalen hypertension
TWI322689B (en) * 2003-02-24 2010-04-01 Otsuka Pharma Co Ltd Method for treating severe heart failure and medicament therefor

Similar Documents

Publication Publication Date Title
JP2006518731A5 (enExample)
RU2008133654A (ru) Способ и лекарственное средство для лечения тяжелой сердечной недостаточности
JP2004519469A5 (enExample)
JP2010077141A5 (enExample)
JP2009536176A5 (enExample)
JP2009102342A5 (enExample)
JP2004522714A5 (enExample)
CN1440283A (zh) 有机化合物的联合形式
JP2006503850A5 (enExample)
JP2010540519A5 (enExample)
JP2019515884A5 (enExample)
JP2009513713A5 (enExample)
JP2010065060A (ja) 心不全処置のための複合治療
JP5362151B2 (ja) Pgd2拮抗剤及びヒスタミン拮抗剤からなるアレルギー性鼻炎治療用医薬
CN105120845A (zh) 药物组合药物
JP2010514834A5 (enExample)
RU2007119067A (ru) Средство для лечения синдрома раздраженного кишечника с преобладанием диареи
US20050256131A1 (en) Pharmaceutical active substance combination and the use thereof
JP2019531286A5 (enExample)
CN101507726B (zh) 窦房结If电流抑制剂和β-阻滞剂的组合
CN101015556B (zh) 窦房结If电流抑制剂与钙抑制剂的组合以及含有它的药物组合物
JP2008543813A5 (enExample)
US20210283096A1 (en) Methods of treating obesity in responder and non-responder populations
JP2008517924A5 (enExample)
JP2015515971A5 (enExample)